SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

MIB 30 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

RECORDATI: Click to view the issuer\'s details

Last update : 09/03/2017  >View issuer details

2019.02.06 | 08:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce RECORDATI OBTAINS EXCLUSIVE LICENSE FOR JUXTAPID® IN JAPAN - HTML (w)

2019.02.06 | 08:30 | Permanent Information Releases / General Company News

Italian version HTML (w) Mail

puce RECORDATI: ACCORDO DI LICENZA PER I DIRITTI ESCLUSIVI ALLA COMMERCIALIZZAZIONE DI JUXTAPID® IN GIAPPONE - HTML (w)

2018.12.21 | 14:04 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce RECORDATI ACQUIRES TONIPHARM S.A.S. IN FRANCE - HTML (w)

2018.12.21 | 14:04 | Permanent Information Releases / General Company News

Italian version HTML (w) Mail

puce RECORDATI ACQUISISCE TONIPHARM S.A.S. IN FRANCIA - HTML (w)

2018.12.20 | 08:32 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce RECORDATI AND HELSINN AGREEMENT FOR THE EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA® - HTML (w)

2018.12.20 | 08:32 | Permanent Information Releases / General Company News

Italian version HTML (w) Mail

puce RECORDATI: ACCORDO CON HELSINN PER I DIRITTI ESCLUSIVI ALLA COMMERCIALIZZAZIONE DI LEDAGA® - HTML (w)

2018.12.05 | 14:16 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce RECORDATI RECEIVES ORPHAN DRUG DESIGNATION FOR ITS INVESTIGATIONAL TREATMENT FOR NEUROTROPHIC KERATITIS - HTML (w)

2018.12.05 | 14:16 | Permanent Information Releases / General Company News

Italian version HTML (w) Mail

puce RECORDATI RICEVE DESIGNAZIONE DI FARMACO ORFANO PER IL SUO TRATTAMENTO SPERIMENTALE DELLA CHERATITE NEUROTROFICA - HTML (w)

2018.11.05 | 15:17 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce RECORDATI RECEIVES ORPHAN DRUG DESIGNATION FOR ITS INVESTIGATIONAL TREATMENT FOR MSUD - HTML (w)

2018.11.05 | 15:17 | Permanent Information Releases / General Company News

Italian version HTML (w) Mail

puce RECORDATI RICEVE DESIGNAZIONE DI FARMACO ORFANO PER IL SUO TRATTAMENTO SPERIMENTALE DELLA MSUD - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 252